More on SYRE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (7/31/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Spyre Therapeutics (NQ:SYRE)
Delayed: 40.15 -0.44 (1.08%)
Prev. Close $40.59  
Open$39.99 
52 Wk High$ 
52 Wk Low$ 
Day High$40.59 
Day Low$38.36 
P/E N/A  
EPS$ 
Volume567,559 

Friends, Peers and Foes (?): NBI (more...)

Mar 6, 2026 04:05 PM Spyre Therapeutics Announces Grants of Inducement Awards
Mar 5, 2026 06:07 AM Form EFFECT Spyre Therapeutics, Inc.
Mar 3, 2026 09:33 PM Form 4 Spyre Therapeutics, Inc. For: Mar 03 Filed by: Burrows Scott L
Mar 3, 2026 09:32 PM Form 4 Spyre Therapeutics, Inc. For: Mar 02 Filed by: Turtle Cameron
Mar 3, 2026 04:45 PM Form 144 Spyre Therapeutics, Inc. Filed by: Burrows Scott L
Mar 2, 2026 04:33 PM Form 144 Spyre Therapeutics, Inc. Filed by: Turtle Cameron
Mar 2, 2026 06:10 AM Form EFFECT Spyre Therapeutics, Inc.
Feb 27, 2026 04:03 PM Form POS AM Spyre Therapeutics, Inc.
Feb 24, 2026 04:05 PM Spyre Therapeutics to Participate in Upcoming March Investor Conferences
Feb 23, 2026 07:00 AM Spyre (SYRE) PT Raised to $55 at Deutsche Bank
View All Articles

Entities mentioned with SYRE

View All Entities